Objective To investigate the clinical significance of the changes of plasma ET and VEGF levels after treatment in patients with diabetic nephropathy.

• 目的:探讨了糖尿病肾病患者治疗前后血浆内皮素和血管内皮生长因子(VEGF)水平的变化及意义。